Small-molecule HIV-1 entry inhibitors targeting gp120 and gp41: a patent review (2010-2015) | |
Li, Wen; Lu, Lu; Li, Weihua; Jiang, Shibo | |
刊名 | EXPERT OPINION ON THERAPEUTIC PATENTS |
2017 | |
卷号 | 27期号:6 |
关键词 | HIV-1 gp120 gp41 small-molecule entry inhibitor C-terminal heptad repeat (CHR) N-terminal heptad repeat (NHR) |
ISSN号 | 1354-3776 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3617191 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Li, Wen,Lu, Lu,Li, Weihua,et al. Small-molecule HIV-1 entry inhibitors targeting gp120 and gp41: a patent review (2010-2015)[J]. EXPERT OPINION ON THERAPEUTIC PATENTS,2017,27(6). |
APA | Li, Wen,Lu, Lu,Li, Weihua,&Jiang, Shibo.(2017).Small-molecule HIV-1 entry inhibitors targeting gp120 and gp41: a patent review (2010-2015).EXPERT OPINION ON THERAPEUTIC PATENTS,27(6). |
MLA | Li, Wen,et al."Small-molecule HIV-1 entry inhibitors targeting gp120 and gp41: a patent review (2010-2015)".EXPERT OPINION ON THERAPEUTIC PATENTS 27.6(2017). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论